Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verena Prokosch

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Experimental Eye Research|November 20, 2021
Chronic social defeat stress causes retinal vascular dysfunctionMaoren Wang, Marija Milic, Adrian Gericke, et al.
Journal of Glaucoma|January 15, 2025
Comparison of Outcomes of Deep Sclerectomy, Canaloplasty, and Viscocanaloplasty: A Multicenter StudyKarl Mercieca, Matthew Azzopardi, Neeru A Vallabh, et al.
American Journal of Ophthalmology|May 20, 2022
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus StatementAnna-Sophie Thein, Anne Hedengran, Augusto Azuara-Blanco, et al.
Cellular and Molecular Neurobiology|August 16, 2024
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular HypertensionMia Langbøl, Arevak Saruhanian, Sarkis Saruhanian, et al.
Cellular and Molecular Neurobiology|October 4, 2024
Correction: Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular HypertensionMia Langbøl, Arevak Saruhanian, Sarkis Saruhanian, et al.
Ophthalmology. Glaucoma|February 11, 2021
What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic ReviewsRiaz Qureshi, Augusto Azuara-Blanco, Manuele Michelessi, et al.
BMJ Open|February 16, 2025
Vision Restoration through transorbital electrical stimulation in Optic Neuropathy in patients with significant optic atrophy due to primary open-angle glaucoma-a randomised, controlled, double-blind, multicentre clinical trial: the VIRON study protocolMichael Schittkowski, Johanna Pohlner, Karl Mercieca, et al.
The British Journal of Ophthalmology|November 3, 2023
European Glaucoma Society research priorities for glaucoma careAugusto Azuara-Blanco, Noleen McCorry, Andrew J Tatham, et al.
Investigative Ophthalmology & Visual Science|October 10, 2015
Comparison of Risk Factor Profiles for Primary Open-Angle Glaucoma Subtypes Defined by Pattern of Visual Field Loss: True Risk Factors or Arbitrary Definition?Gokulan Ratnarajan, Cornelia Hirn, Eduardo Normando, et al.
Progress in Retinal and Eye Research|February 9, 2023
The novel role of lymphatic vessels in the pathogenesis of ocular diseasesThomas Clahsen, Karina Hadrian, Maria Notara, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Experimental Eye Research|November 20, 2021
Chronic social defeat stress causes retinal vascular dysfunctionMaoren Wang, Marija Milic, Adrian Gericke, et al.
Journal of Glaucoma|January 15, 2025
Comparison of Outcomes of Deep Sclerectomy, Canaloplasty, and Viscocanaloplasty: A Multicenter StudyKarl Mercieca, Matthew Azzopardi, Neeru A Vallabh, et al.
American Journal of Ophthalmology|May 20, 2022
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus StatementAnna-Sophie Thein, Anne Hedengran, Augusto Azuara-Blanco, et al.
Cellular and Molecular Neurobiology|August 16, 2024
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular HypertensionMia Langbøl, Arevak Saruhanian, Sarkis Saruhanian, et al.
Cellular and Molecular Neurobiology|October 4, 2024
Correction: Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular HypertensionMia Langbøl, Arevak Saruhanian, Sarkis Saruhanian, et al.
Ophthalmology. Glaucoma|February 11, 2021
What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic ReviewsRiaz Qureshi, Augusto Azuara-Blanco, Manuele Michelessi, et al.
BMJ Open|February 16, 2025
Vision Restoration through transorbital electrical stimulation in Optic Neuropathy in patients with significant optic atrophy due to primary open-angle glaucoma-a randomised, controlled, double-blind, multicentre clinical trial: the VIRON study protocolMichael Schittkowski, Johanna Pohlner, Karl Mercieca, et al.
The British Journal of Ophthalmology|November 3, 2023
European Glaucoma Society research priorities for glaucoma careAugusto Azuara-Blanco, Noleen McCorry, Andrew J Tatham, et al.
Investigative Ophthalmology & Visual Science|October 10, 2015
Comparison of Risk Factor Profiles for Primary Open-Angle Glaucoma Subtypes Defined by Pattern of Visual Field Loss: True Risk Factors or Arbitrary Definition?Gokulan Ratnarajan, Cornelia Hirn, Eduardo Normando, et al.
Progress in Retinal and Eye Research|February 9, 2023
The novel role of lymphatic vessels in the pathogenesis of ocular diseasesThomas Clahsen, Karina Hadrian, Maria Notara, et al.
Pageof 12